Vincennes, France

Jean-Dominique Boursat

This inventor holds 1 USPTO granted patent. Top assignee: Rhone-Poulenc Rorer S.a.. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean-Dominique Boursat. Retrieved from https://idiyas.com/inventor/jean-dominique-boursat

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Jean-Dominique Boursat

Introduction

Jean-Dominique Boursat is a notable inventor based in Vincennes, France. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of taxanes, which are vital in cancer treatment.

Latest Patents

Boursat holds a patent for the "Process for the preparation of 7-hydroxytaxanes." This innovation is crucial for enhancing the efficacy of taxane-based therapies, which are widely used in oncology.

Career Highlights

Boursat is associated with Rhone-Poulenc Rorer S.A., a prominent company in the pharmaceutical industry. His work there has focused on developing advanced methods for drug preparation and formulation.

Collaborations

Throughout his career, Boursat has collaborated with esteemed colleagues such as Jean-Pierre Bastart and Alain Commercon. These partnerships have fostered a collaborative environment that encourages innovation and research.

Conclusion

Jean-Dominique Boursat's contributions to the field of pharmaceuticals through his patent and collaborations highlight his role as an influential inventor. His work continues to impact cancer treatment methodologies significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…